Biotech & MedTech
-
StageZero Life Sciences’ Aristotle 10 in 1 cancer screening test looks set to launch in Q1 2021
StageZero Life Sciences Ltd. (TSX: SZLS) (‘StageZero’) has been developing their Aristotle 10 in 1 cancer screening test…
-
Valeo Pharma’s approval and launch of immune support product line Redesca and Redesca HP anticipated to impact first half 2021 revenue
Most investors know that the pharmaceutical industry is a huge and mostly very profitable industry. What they may…
-
Diagnos’ Andre Larente on the benefits of using AI for the early detection of critical health issues
“Our (AI) technology works, its in production (CARA). We are fully funded….the markets we are going after are…
-
Sixth Wave’s Dr. Jon Gluckman talks about the election and the 2nd wave of cannabis investment
In a recent InvestorIntel interview, Tracy Weslosky speaks with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
Sixth Wave’s Dr Jon Gluckman on the competitive advantages of Molecular Imprint Polymers for the rapid detection of viruses
In a recent InvestorIntel interview, Tracy Weslosky speaks with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
Punching above their weight, Predictmedix keeps nailing the heavyweight health tech partnerships
As the world shifts to a “new” normal, employee and customer screenings will be commonplace and Predictmedix Inc.…
-
Biden’s win brings a “green” market wave and cannabis extraction team attracts the Sixth Wave
“Waves are inspiring not because they rise and fail, but because each time they fall. They never fail…
-
Dr. Rahul Kushwah on Predictmedix’s remote patient monitoring technology and Mobile Wellbeing
In a recent InvestorIntel interview, Tracy Weslosky speaks with Dr. Rahul Kushwah, Co-Founder and COO of Predictmedix Inc.…
-
Diagnos’ AI Platform to Fight Vision Loss Continues to Expand Globally
Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) is a software platform provider for the early detection of critical…
-
Michael Lende on a Health Canada approved touchless fever detection system that can help identify potential at-risk carriers
Peter Clausi with Predictiv AI CEO Michael Lende on the touchless ThermalPass Fever Detection System In a recent…